Cancer Genetics Inc (CGIX) Stock News
NASDAQ:CGIX - Nasdaq -
CGIX Latest News, Press Relases and Analysis
12 Health Care Stocks Moving In Thursday's Intraday Session
Gainers ProQR Therapeutics (NASDAQ:PRQR) stock moved upwards by 48.06% to $8.41 during Thursday's regular session. The current volume of 71.3 million shares is 9524.89...
Mid-Day Market Update: Crude Oil Down Over 4%; Cellect Biotechnology Shares Surge
Midway through trading Thursday, the Dow traded down 1% to 32,096.94 while the NASDAQ fell 1.28% to 12,796.15. The S&P also fell, dropping 0.89% to 3,854.71. The U.S. has the...
Looking For Biotech Stocks To Buy Now? 4 Names To Know
As the biotech companies continue to unveil new drugs and therapies, these biotech stocks are in focus.
CGIX Stock: Why Cancer Genetics Shares Are Rocketing Higher Today
CGIX stock is on the move Wednesday ahead of a shareholder vote on its merger with StemoniX. Here's what you should know now.
INVESTIGATION ALERT: Halper Sadeh LLP Investigates PRGX, RP, NK, CGIX; Shareholders Are Encouraged to Contact the Firm
INVESTIGATION ALERT: Halper Sadeh LLP Investigates PRGX, RP, NK, CGIX; Shareholders Are Encouraged to Contact the Firm NEW YORK, NY / ACCESSWIRE / February 4, 2021 / Halper Sadeh LLP, a global investor rights law firm, continues to investigate the following companies: PRGX Global, Inc. (NASDAQ: PRGX) concerning potential violations of the federal securities laws and/or breaches of fiduciary duties relating to its sale to Ardian